Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The partnership aims to equip students and faculty with knowledge of evolving pharmaceutical and regulatory landscapes.
March 19, 2026
By: Patrick Lavery
Content Marketing Editor
Roche Pharma India has signed a Memorandum of Understanding with the National Institute of Pharmaceutical Education and Research (NIPER) Raebareli. The agreement intends to foster academic–industry collaboration, and strengthen pharmaceutical education and research, within India.
Officials announcing the partnership said they see India strengthening as a global hub for biopharmaceutical innovation.
“Partnerships like these … enable stronger industry-academia linkage for innovation,” said Roche Pharma India Managing Director and CEO Rajwinder Mehdwan.
Mehdwan added this may lead to “sustained global competitive advantage” for India’s biopharma sector.
Roche and NIPER Raebareli say they want to “bridge the gap” between academic learning and real-world practices in the industry. To accomplish this, they seek to equip both students and faculty with knowledge of evolving pharmaceutical and regulatory settings.
Several options can be chosen by participants:
Initiatives like these, the involved parties say, will not only help build a skilled workforce but also encourage further research. Altogether, research into advancements in pharmaceutical technologies will promote a stronger, more resilient healthcare system.
Roche Pharma already signed another Memorandum of Understanding, in February 2026, with NIPER Mohali. Among the areas this agreement covers: curriculum design and development, student mentorship, and delivery of industry-ready short-term courses.
Ultimately, the two NIPERs and Roche envision the creation of a “collaborative industry-academia ecosystem” to help drive innovation.
“This … represents an important step in strengthening academic excellence and industry relevance,” said NIPER Raebareli Director Shubhini A. Saraf.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !